About SMSG
The Singapore Myeloma Study Group (SMSG) brings together local myeloma experts to conduct research, run clinical trials, and set treatment guidelines for myeloma patients in Singapore.
About the Singapore Myeloma Study Group (SMSG)
The Singapore Myeloma Study Group (SMSG) was established to carry out research including clinical trials to bring promising new treatment to Singapore Myeloma patients. We also form the expert group in Singapore that develop practice guidelines. Members comprise myeloma experts from public and private healthcare organizations in Singapore. Many of the members are also part of the Asian Myeloma Network (AMN), formed under the auspices of the International Myeloma Foundation (IMF), and are active in leading and driving many of AMN’s activities including clinical trials, physician education and patient support outreach through the network.
The SMSG is currently led by Prof Chng Wee Joo, Executive Director of the Singapore Translational Cancer Consortium.